U.S. flag

An official website of the United States government

NM_001199107.2(TBC1D24):c.1008del (p.His336fs) AND DOORS syndrome

Germline classification:
Pathogenic (5 submissions)
Last evaluated:
Jun 7, 2019
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000076916.20

Allele description [Variation Report for NM_001199107.2(TBC1D24):c.1008del (p.His336fs)]

NM_001199107.2(TBC1D24):c.1008del (p.His336fs)

Gene:
TBC1D24:TBC1 domain family member 24 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_001199107.2(TBC1D24):c.1008del (p.His336fs)
HGVS:
  • NC_000016.10:g.2498262del
  • NG_028170.1:g.28117del
  • NM_001199107.2:c.1008delMANE SELECT
  • NM_020705.3:c.990del
  • NP_001186036.1:p.His336fs
  • NP_065756.1:p.His330fs
  • NC_000016.9:g.2548263del
  • NM_001199107.1:c.1008del
  • NM_001199107.1:c.1008delT
  • NM_001199107.2:c.1008delTMANE SELECT
  • NP_001186036.1:p.His336Glnfs*12
  • p.H336QfsX12
Protein change:
H330fs
Links:
OMIM: 613577.0010; dbSNP: rs398122967
NCBI 1000 Genomes Browser:
rs398122967
Molecular consequence:
  • NM_001199107.2:c.1008del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_020705.3:c.990del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
DOORS syndrome (DOORS)
Synonyms:
DOOR SYNDROME; Deafness onychodystrophy osteodystrophy and mental retardation syndrome; DRC SYNDROME; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009079; MedGen: C0795934; Orphanet: 3231; Orphanet: 79500; OMIM: 220500

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000108713OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 2014)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000211969Division of Medical Genetics; Sainte-Justine Hospital
no assertion criteria provided
Pathogenic
(Dec 22, 2014)
germlineliterature only

Citation Link,

SCV000266462Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
criteria provided, single submitter

(Campeau et al. (Lancet Neurol 2014))
Pathogenic
(Jan 1, 2014)
germlineresearch

PubMed (5)
[See all records that cite these PMIDs]

SCV001150278Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
criteria provided, single submitter

(Classification criteria August 2017)
Pathogenic
(Jun 7, 2019)
maternalclinical testing

Citation Link,

SCV002106362GeneReviews
no classification provided
not providedgermlineliterature only

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes12not providednot providednot providedliterature only, research
not providedgermlineno3not providednot providednot providednot providedresearch
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedliterature only
not providedmaternalyes1not providednot provided1not providedclinical testing

Citations

PubMed

DOORS syndrome: phenotype, genotype and comparison with Coffin-Siris syndrome.

Campeau PM, Hennekam RC; DOORS syndrome collaborative group.

Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):327-32. doi: 10.1002/ajmg.c.31412. Epub 2014 Aug 28.

PubMed [citation]
PMID:
25169651

TBC1D24-Related Disorders..

Balestrini S, Campeau PM, Mei D, Guerrini R, Sisodiya S.

2015 Feb 26 [updated 2024 Oct 24]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025.

PubMed [citation]
PMID:
25719194
See all PubMed Citations (5)

Details of each submission

From OMIM, SCV000108713.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a German patient with deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome (DOORS; 220500), Campeau et al. (2014) identified compound heterozygosity for 2 mutations in the TBC1D24 gene: a 1-bp deletion (c.1008delT), resulting in a frameshift and premature termination (His336GlnfsTer12), and a splice site mutation in intron 5 (c.1206+5G-A; 613577.0011). The heterozygous c.1008delT mutation was found in 2 of 6,118 individuals in the Exome Variant Server. Fibroblasts from this patient showed 5% TBC1D24 mRNA and no detectable protein compared to controls, consistent with a loss of function. An unrelated French patient was heterozygous for the c.1008delT mutation, but a second mutation was not identified.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Division of Medical Genetics; Sainte-Justine Hospital, SCV000211969.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine, SCV000266462.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (5)
2not provided3not providednot providedresearch PubMed (5)

Description

We identified 26 families with DOORS syndrome; each patient had at least 3 of the 5 well-described features of DOORS syndrome, which include deafness, onychodystrophy, osteodystrophy, intellectual disability, and seizures. A combination of whole-exome sequencing and Sanger sequencing identified homozygous or compound heterozygous pathogenic variants in TBC1D24 in 11 individuals from 9 families.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not provided2not provided
2germlinenonot providednot providednot provided3not providednot providednot provided

From Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München, SCV001150278.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyes1bloodnot provided1not providednot providednot provided

From GeneReviews, SCV002106362.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2025